Transaction in Own Shares

Summary by AI BETAClose X

Smith & Nephew plc has purchased 659,038 of its own ordinary shares between July 24 and July 30, 2026, as part of its $250 million share buyback program. These repurchases, executed by Merrill Lynch International, ranged in price from 1,115.00p to 1,222.00p per share, with an average price of 11.7446p. The company now holds 37,876,589 shares in treasury, and its total issued share capital, excluding treasury shares, stands at 839,857,161 ordinary shares.

Disclaimer*

Smith & Nephew Plc
31 July 2026
 

31 July 2026

Smith & Nephew plc
Transactions in own shares

 

Smith & Nephew plc (the "Company") announces that from 24 July 2026 up to and including 30 July 2026 it has purchased the following number of its own ordinary shares of US 20¢ each through Merrill Lynch International, as part of its USD $250 million share buyback programme announced on 6 May 2026 and in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 6 May 2026.

 

Date of purchase

Aggregate number of ordinary shares purchased

Lowest price paid per ordinary share

Highest price paid per ordinary share

Average price paid per ordinary share

24 Jul 2026

168,847

1,115.00p

1,143.50p

1,130.34p

27 Jul 2026

132,216

1,147.50p

1,169.50p

1,160.73p

28 Jul 2026

120,757

1,162.00p

1,211.50p

1,193.22p

29 Jul 2026

116,135

1,193.00p

1,222.00p

1,210.39p

30 Jul 2026

121,083

1,186.00p

1,216.50p

1,197.81p

 

The Company intends to hold these shares in Treasury and then either cancel them or retain them for the purpose of satisfying awards under the Company's employee share plans.

 

Since 8 May 2026, the Company has purchased 14,259,797 shares at a cost of $215,210,613.08.

 

Following the purchases of these shares, the Company holds 37,876,589 of its ordinary shares in treasury. The Company's issued share capital, with one voting right per share consists of 839,857,161 ordinary shares of US20¢ each (excluding treasury shares). The figure of 839,857,161 should be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

These purchases were made by Merrill Lynch International on behalf of the Company.

This announcement is made in accordance with the requirements of UKLR 9.6.6R.

The table below contains detailed information about the purchases made as part of the buyback programme.

 

Schedule of Purchases

 

Shares purchased:          659,038 (ISIN: GB0009223206)

 

Dates of purchases:        24 July 2026 to 30 July 2026

 

Investment firm:               Merrill Lynch International

 

Aggregate information:

 

Venue

Volume weighted average price paid per ordinary share (GBP)

Number of ordinary shares repurchased

Lowest price per ordinary share (GBP)

Highest price per ordinary share (GBP)

London Stock Exchange

11.7446

659,038

11.1500

12.2200

CBOE Europe BXE

-

-

-

-

CBOE Europe CXE

-

-

-

-

Turquoise

-

-

-

-

Aquis Stock Exchange

-

-

-

-

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), a schedule of individual trades by Merrill Lynch International is available below:

 

Individual Transactions:

The table attached contains detailed information of the individual trades made by Merrill Lynch International, as part of the buyback programme.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/7525O_1-2026-7-31.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings